Special patient preparation for PET/CT in suspected cardiac and vascular infection

2021 ◽  
Vol 14 (3) ◽  
pp. 179
Author(s):  
I.P. Aslanidi ◽  
D.M. Pursanova ◽  
O.V. Mukhortova ◽  
I.V. Shurupova ◽  
I.V. Ekaeva ◽  
...  
2014 ◽  
Vol 42 (1) ◽  
pp. 5-13 ◽  
Author(s):  
D. S. Surasi ◽  
P. Bhambhvani ◽  
J. A. Baldwin ◽  
S. E. Almodovar ◽  
J. P. O'Malley

2018 ◽  
Vol 19 (1) ◽  
pp. 68
Author(s):  
Fatima Begum ◽  
Raihan Hussain ◽  
Shamim Momtaz Ferdousi Begum ◽  
Mizanul Hasan

<p><span>Abstract not available</span></p><p><span>Bangladesh J. Nuclear Med. 19(1): 68-69, January 2016</span></p>


2019 ◽  
Vol 160 (26) ◽  
pp. 1015-1024
Author(s):  
Zsuzsanna Besenyi ◽  
Ferenc Tamás Nagy ◽  
László Sághy ◽  
László Pávics

Abstract: Over the past decades, 18F-FDG-PET/CT imaging has been recognized as an indispensable tool in the diagnosis, staging and treatment monitoring of cancer. This modern imaging technique combining functional and morphologic information has approved indications not only in oncology but in clinical cardiology as well. In the current review we discuss the specific requirements of patient preparation and image acquisition protocol for cardiac 18F-FDG-PET/CT. We review the literature in some cases highlighted by our own examinations of well-known “gold standard” viability and onco-cardiology examinations while placing special emphasis on inflammatory disorders involving the heart. This relatively newer class of indications includes prosthetic valve endocarditis, cardiac implantable device infection, myocardial inflammation of varying origin such as sarcoidosis where 18F-FDG-PET/CT appears to be particularly useful in the differential diagnosis of cases where standard investigation is non-diagnostic or equivocal. Orv Hetil. 2019; 160(26): 1015–1024.


2019 ◽  
Vol 92 (1101) ◽  
pp. 20181027 ◽  
Author(s):  
Maureen Dumba ◽  
Sairah Khan ◽  
Neva Patel ◽  
Laura Perry ◽  
Paresh Malhotra ◽  
...  

The number of people living with dementia is increasing, but as yet there remains no cure or disease-modifying treatment. This review aims to help readers understand the role of18F-FDG PET/CT imaging in the investigation of cognitive impairment and how the advent of amyloid PET/CT imaging may hold the key to radically changing management of the most common form of dementia - Alzheimer’s disease.The indications for18F-FDG PET/CT and amyloid PET/CT imaging in cognitive impairment are outlined. Additionally, the mechanisms of action, technique, patient preparation and acquisition parameters for both are detailed. We conclude by providing a framework for interpreting18F-FDG PET/CT and amyloid PET/CT imaging in the more common conditions that lead to cognitive impairment conditions with tips on avoiding pitfalls in interpretation.


PET Clinics ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. 125-134
Author(s):  
Søren Hess ◽  
Asbjørn Mathias Scholtens ◽  
Lars Christian Gormsen

PET Clinics ◽  
2008 ◽  
Vol 3 (4) ◽  
pp. 473-485 ◽  
Author(s):  
Michael J. Gelfand ◽  
Susan E. Sharp

2005 ◽  
Vol 173 (4S) ◽  
pp. 432-432
Author(s):  
Georg C. Bartsch ◽  
Norbert Blumstein ◽  
Ludwig J. Rinnab ◽  
Richard E. Hautmann ◽  
Peter M. Messer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document